Related Experiment Video
Updated: Mar 31, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Worsening Kidney Function and Cardiovascular Outcomes in Type 2 Diabetes and Atherosclerotic Disease
Abhinav Sharma1, Amir Razaghizad1, Susanna R Stevens2
1DREAM-CV Lab, Research Institute of the McGill University Health Centre (MUHC), Montreal, Quebec, Canada.
Insights
Worsening kidney function (WKF) is common in type 2 diabetes (T2D) patients with cardiovascular disease and increases risks for major adverse cardiovascular events (MACE4) and severe hypoglycemia.
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
Background:
- The relationship between worsening kidney function (WKF) and cardiovascular outcomes in patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD) requires further elucidation.
- Understanding this bidirectional association is crucial for managing T2D patients with existing ASCVD.
Purpose of the Study:
- To investigate the association between nonfatal cardiovascular events and WKF in T2D patients with ASCVD.
- To evaluate the link between severe hypoglycemia and WKF in this patient population.
Main Methods:
- Analysis of data from the TECOS trial, including 14,671 patients with T2D and ASCVD.
- Primary outcome: 4-component major adverse cardiovascular event (MACE4). Secondary outcome: hospitalization for heart failure (hHF).
- WKF defined as ≥40% glomerular filtration rate decline or renal replacement therapy initiation; Cox proportional hazards models used.
Main Results:
- Worsening kidney function (WKF) occurred in 7.0% of patients over a median 3-year follow-up.
- WKF risk was elevated following nonfatal myocardial infarction, stroke, unstable angina, and particularly after hospitalization for heart failure (hHF).
- WKF was significantly associated with increased risks of MACE4, hHF, and severe hypoglycemia.
Conclusions:
- Worsening kidney function (WKF) is a prevalent issue in patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD).
- WKF is strongly linked to adverse cardiovascular outcomes and severe hypoglycemia.
- Early implementation of cardiorenal therapies is recommended for this high-risk group.
Background:
The bidirectional association between worsening kidney function (WKF) and cardiovascular outcomes in type 2 diabetes (T2D) patients with atherosclerotic cardiovascular disease (ASCVD) is unclear.
Objectives:
This study aimed to evaluate the bidirectional association between: 1) nonfatal cardiovascular events and WKF; and 2) severe hypoglycemia and WKF.
Methods:
We analyzed data from TECOS (Trial Evaluating Cardiovascular Outcomes with Sitagliptin), enrolling 14,671 patients with T2D and ASCVD randomized to sitagliptin or placebo. The primary outcome was a 4-component major adverse cardiovascular event (MACE4) comprising nonfatal myocardial infarction, stroke, cardiovascular death, or unstable angina hospitalization. We also examined hospitalization for heart failure (hHF). WKF was defined as a glomerular filtration rate decline of ≥40% (per the Modification of Diet in Renal Disease formula) or initiation of renal replacement therapy. Cox proportional hazards models assessed associations between WKF and subsequent MACE4 and hHF.
Results:
Over a median 3-year follow-up, 1,030 (7.0%) experienced WKF. Overall, WKF risk increased after nonfatal myocardial infarction, stroke, or unstable angina (adjusted HR [HRadj]: 2.0; 95% CI: 1.6-2.5) and was higher after hHF (HRadj: 6.1; 95% CI: 4.8-7.9). Median estimated glomerular filtration rate declines before MACE4 and hHF were -3.8% (IQR: -17.4, 9.4) and -9.2% (IQR: -22.7, 6.6), respectively. WKF was associated with increased risks of MACE4 (HRadj: 1.9; 95% CI: 1.5-2.4), hHF (HRadj: 3.2; 95% CI: 2.2-4.6), and severe hypoglycemia (HRadj: 2.8; 95% CI: 1.8-4.4).
Conclusions:
In patients with T2D and ASCVD, WKF is common and linked to adverse cardiovascular outcomes and severe hypoglycemia, highlighting the need for early cardiorenal therapies.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Heart Failure Drugs: Diuretics
Kidney Transplant I: Introduction
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Type 2 and Gestational
Coronary Artery Disease I: Introduction

